HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Efficacy of an inactivated recombinant vaccine encoding a fimbrial protein of Pasteurella multocida B:2 against hemorrhagic septicemia in goats.

Abstract
This study was carried out to determine the antibody responses and protective capacity of an inactivated recombinant vaccine expressing the fimbrial protein of Pasteurella multocida B:2 following intranasal vaccination against hemorrhagic septicemia in goats. Goats were vaccinated intranasal with 10(6) CFU/mL of the recombinant vaccine (vaccinated group) and 10(6) CFU/mL of pET32/LIC vector without fimbrial protein (control group). All three groups were kept separated before all goats in the three groups were challenged with 10(9) CFU/mL of live pathogenic P. multocida B:2. During the course of study, both serum and lung lavage fluid were collected to evaluate the antibody levels via enzyme-linked immunosorbent assay. It was found that goats immunized with the inactivated recombinant vaccine developed a strong and significantly (p < 0.05) higher specific IgA and IgG responses in both serum and lung lavage fluid samples compared to the control and unvaccinated groups. Following intratracheal challenge, the rate of isolation was 17% for the vaccinated group, 67% for the control group and 100% for the unvaccinated group. However, none of the goat from the vaccinated group had P. multocida B:2 in the liver, tonsil and heart. Therefore, the study revealed that an inactivated recombinant vaccine significantly provides significant protection against high dose challenge and enhances the stimulation of the local and systemic immunities.
AuthorsIna-Salwany Mohd Yasin, Sabri Mohd Yusoff, Zamri-Saad Mohd, Effendy Abd Wahid Mohd
JournalTropical animal health and production (Trop Anim Health Prod) Vol. 43 Issue 1 Pg. 179-87 (Jan 2011) ISSN: 1573-7438 [Electronic] United States
PMID20697957 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antigens, Bacterial
  • Bacterial Vaccines
  • DNA Primers
  • Vaccines, Inactivated
  • Fimbriae Proteins
Topics
  • Amino Acid Sequence
  • Animals
  • Antigens, Bacterial (immunology)
  • Bacterial Vaccines (pharmacology, therapeutic use)
  • Base Sequence
  • DNA Primers (genetics)
  • Fimbriae Proteins (genetics, immunology)
  • Goat Diseases (microbiology, prevention & control)
  • Goats
  • Hemorrhagic Septicemia (prevention & control, veterinary)
  • Molecular Sequence Data
  • Pasteurella multocida (immunology)
  • Plasmids (genetics)
  • Polymerase Chain Reaction
  • Sequence Alignment
  • Treatment Outcome
  • Vaccination (methods, veterinary)
  • Vaccines, Inactivated (pharmacology, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: